Showing results (941-950 of 8,009) with videos related to
Sort By:
Pageof 801
Current Medicinal Chemistry|February 16, 2013
Profiling the structural determinants of heteroarylnitrile scaffold-based derivatives as falcipain-2 inhibitors by in silico methodsJinghui Wang, Yan Li, Yinfeng Yang, et al.Current Medicinal Chemistry|February 16, 2013
The economics of polypharmacology: fixed dose combinations and drug cocktailsA I WertheimerCurrent Medicinal Chemistry|February 16, 2013
Multi-target compounds acting in the central nervous system designed from natural productsX Chen, M DeckerCurrent Medicinal Chemistry|February 16, 2013
Rationally designed multitarget anticancer agentsZhuo Chen, Le Han, Minghao Xu, et al.Current Medicinal Chemistry|February 16, 2013
MicroRNA-mediated control of prostate cancer metastasis: implications for the identification of novel biomarkers and therapeutic targetsNicola Fenderico, Anna Casamichele, Valentina Profumo, et al.Current Medicinal Chemistry|February 16, 2013
Recent advances in drug design of epidermal growth factor receptor inhibitorsP Warnault, A Yasri, M Coisy-Quivy, et al.Current Medicinal Chemistry|January 10, 2013
Silver nanoparticles in cancer: therapeutic efficacy and toxicityC Ong, J Z Z Lim, C-T Ng, et al.Current Medicinal Chemistry|April 20, 2013
Synthetic approaches towards the marine alkyl purinesM Gordaliza, P G BaraldiCurrent Medicinal Chemistry|April 20, 2013
Could growth factor-mediated extracellular matrix deposition and degradation offer the ground for directed pharmacological targeting in fibrosarcoma?D Nikitovic, A Berdiaki, A Banos, et al.Current Medicinal Chemistry|July 16, 2013
Gallic acid attenuates oleic acid-induced proliferation of vascular smooth muscle cell through regulation of AMPK-eNOS-FAS signalingTing-Tsz Ou, Ming-Cheng Lin, Cheng-Hsun Wu, et al.Pageof 801